Cargando…
The “7+3” regimen in acute myeloid leukemia
Autor principal: | Rowe, Jacob M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Fondazione Ferrata Storti
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8719100/ https://www.ncbi.nlm.nih.gov/pubmed/34985228 http://dx.doi.org/10.3324/haematol.2021.280161 |
Ejemplares similares
-
Chasing quality remission in acute myeloid leukemia: intensity of induction and residual disease
por: Ofran, Yishai
Publicado: (2023) -
t(15;17) in acute promyelocytc leukemia
por: Ling, Victoria Y., et al.
Publicado: (2023) -
TCF3::HLF acute lymphoblastic leukemia: still challenging to cure thirty years later
por: Tasian, Sarah K.
Publicado: (2023) -
Clonal evolution of leukemia from G6PD studies
por: Bacharach, Tal, et al.
Publicado: (2023) -
The first achievement of complete remission in childhood leukemia by treatment with the folic acid antagonist aminopterin
por: Izraeli, Shai
Publicado: (2022)